To understand causality beyond observational studies, Mendelian randomization (MR) has provided compelling evidence linking CHIP-associated DNA methylation (Dnam) in genes to coronary artery disease (CAD) risk. The gene discussed is STUB1; the disease is coronary artery disorder.